This study aimed to evaluate the utility of PSA derivatives in diagnosing PCa among men with low to intermediate PSA levels (≤10 ng/mL), a population that presents a diagnostic challenge due to the overlap of values between benign and malignant prostate conditions. This evidence concerns the gene KLK3 and posterior cortical atrophy.